226
Clostridium difficile: Treatment and Prevention
Saturday, October 11, 2014: 2:00 PM-3:30 PM
Room: The Pennsylvania Convention Center: 107-AB
Learning Objectives:
-
Target Audience: Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Epidemiologists, Clinicians
Tracks: Pediatric ID, Epidemiology and Infection Control, Adult ID
Moderators:
Erik Dubberke, MD, MSPH, Washington University School of Medicine
and
Deverick Anderson, MD, MPH, Duke University Medical Center
Presentations:
2:30 PM
Recovery of Clostridium difficile, Vancomycin Resistant Enterococcus and Methicillin Resistant Staphylococcus aureus from the Food of Hospitalized Patients
Jennie H. Kwon, D.O.
;
Kerry M. Bommarito, MPH
;
Kimberly Reske, MPH
;
Tiffany Hink, BS
;
Sondra Seiler, BA
;
Meghan Wallace, B.A.
;
Carey-Ann D. Burnham, PhD
;
Erik Dubberke, MD, MSPH
2:45 PM
The Cost-Benefit of Federal Investment in Preventing Clostridium difficile Infections through the Use of a Multifaceted Infection Control and Antimicrobial Stewardship Program
Rachel Slayton, PhD, MPH
;
James Baggs, PhD
;
R. Douglas Scott, PhD
;
Fernanda Lessa, MD
;
L. Clifford Mcdonald, MD, FACP, FSHEA
;
John Jernigan, MD, MS
CME Credits:
ACPE Credits:
ACPE Number:
Disclosures:
E. Dubberke,
rebiotix: Consultant and Investigator, Consulting fee and Research support
sanofi pasteur: Consultant and Investigator, Consulting fee and Grant recipient
merck: Consultant and Grant Investigator, Consulting fee and Research support
cubist: Consultant and Investigator, Consulting fee and Research support
D. Anderson,
None